On day 7 after stopping lurasidone (Latuda), when is the restlessness (akathisia) expected to resolve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Akathisia After Stopping Latuda: Expected Resolution Timeline

Your restlessness (akathisia) should resolve within 3-7 days after stopping Latuda, though in some cases it may take up to 2-3 weeks for complete resolution.

Understanding the Timeline

Akathisia from antipsychotics like lurasidone (Latuda) typically occurs during active treatment, not after discontinuation. Since you're on day 7 off the medication, you're likely experiencing withdrawal-related restlessness rather than ongoing drug-induced akathisia. The distinction matters for management:

Acute Withdrawal Phase (Days 1-7)

  • Restlessness and akathisia-like symptoms can emerge as withdrawal symptoms when antipsychotics are stopped 1
  • These symptoms typically peak in the first few days and begin improving by day 7
  • The half-life of lurasidone is approximately 18 hours, meaning the drug should be essentially cleared from your system by day 4-5

Expected Resolution Window

  • Most patients: Symptoms resolve within 3-7 days of discontinuation 2
  • Some patients: May experience symptoms for 1-3 weeks 3
  • Rare cases: A small subset may have protracted withdrawal symptoms lasting several weeks 4

Why Restlessness Persists After Stopping

The restlessness you're experiencing at day 7 likely represents:

  1. Dopamine receptor readjustment: Your brain's dopamine receptors are recalibrating after chronic D2 blockade
  2. Withdrawal akathisia: A rebound phenomenon as the antipsychotic effect wears off 5
  3. Gradual normalization: The subjective feeling of restlessness should progressively diminish over the next 1-2 weeks

Management Strategies

While waiting for resolution:

  • Beta-blockers (like propranolol) can help manage persistent akathisia symptoms if they're severe 5
  • Benzodiazepines may provide short-term relief for severe restlessness 5
  • Avoid restarting the antipsychotic, as this will only prolong the adjustment period
  • Maintain regular sleep-wake cycles and light physical activity

Red Flags Requiring Medical Attention

Contact your prescriber if you experience:

  • Worsening restlessness beyond day 10-14
  • Severe agitation or inability to sit still
  • New onset of muscle rigidity, fever, or confusion (signs of neuroleptic malignant syndrome, though rare after discontinuation) 1
  • Suicidal thoughts or severe mood changes

Important Caveat

Abrupt discontinuation of antipsychotics can cause withdrawal symptoms and should ideally be avoided 2. If you stopped Latuda suddenly without medical guidance, inform your prescriber. Gradual tapering over several weeks minimizes withdrawal effects, though at day 7 post-discontinuation, restarting and tapering slowly may cause more harm than benefit.

The evidence suggests that by day 14 off Latuda, the vast majority of withdrawal-related restlessness should have resolved. If symptoms persist beyond 2-3 weeks, reassessment for other causes is warranted.

Related Questions

What are the differences in effects and side‑effect profiles between lurasidone (Latuda) and aripiprazole (Abilify)?
How do the antipsychotic properties of lurasidone compare to those of aripiprazole, and does either drug have stronger antipsychotic efficacy?
On day 6 after discontinuing lurasidone (Latuda), when is the akathisia (restlessness) expected to resolve?
What adjunct medication and dose are recommended to treat jitteriness (possible akathisia) in a patient taking Latuda (lurasidone) 60 mg who consumes more than six caffeinated beverages (e.g., Mountain Dew) daily?
Can a patient with Bipolar I disorder who developed akathisia from aripiprazole (Abilify) and lurasidone (Latuda) be started on brexpiprazole (Rexulti)?
Should an additional diuretic be prescribed for a patient already taking Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) each morning who has low nighttime blood pressure and signs of volume depletion?
For a patient scheduled for sacrocolpopexy who is taking methocarbamol (Robaxin) 750 mg orally every 6 hours, should the medication be continued up to the day of surgery and how should the dosing be adjusted?
What empiric intravenous antibiotic regimen should be used for cellulitis in a patient receiving hemodialysis, including dosing adjustments for the dialysis schedule?
How can I manage excessive sleep duration and difficulty waking up for work, given that I sleep 10–12 hours on days off and struggle to wake early for my job?
In a patient with stage 2 chronic kidney disease (estimated glomerular filtration rate 60–89 mL/min/1.73 m²), should the dose of methocarbamol be reduced or adjusted?
How should a diabetic foot infection presenting with arch pain and great‑toe paralysis be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.